EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Site-Specific Radioiodination of Anti-EGFR-Targeted DARPin E01 Using (4-Hydroxyphenyl)ethyl Maleimide

Mariia Larkina iD, Gleb Yanovich iD, Lutfi A Hasnowo iD, Ruslan Varvashenya iD, Daria Eskova, Ivan Sharychev, Anastasia Prach iD, Evgenii Plotnikov iD, Roman Zelchan, Alexey Schulga iD, Elena Konovalova iD, Rustam H Ziganshin iD und 3 weitere

International Journal of Molecular Sciences · 20.08.2026 · 27 (16) · 7438

DOI: 10.3390/ijms27167438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.08.2026. Verfasst von Mariia Larkina und 14 weiteren Autor:innen. Beteiligte Einrichtung: Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russ…. Hauptthemen laut MEDLINE: Iodine Radioisotopes, ErbB Receptors, Maleimides, Radiopharmaceuticals. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-invasive radionuclide molecular imaging of epidermal growth factor receptor (EGFR) expression can guide patient stratification for EGFR-targeted therapies. The designed ankyrin repeat protein (DARPin) E01, which binds EGFR ectodomain III with sub-nanomolar affinity, is a promising scaffold for single-photon emission computed tomography (SPECT) imaging probes. In the present study, we compared site-specific radioiodination of DARPin E01 using the bifunctional prosthetic group (4-hydroxyphenyl)ethyl maleimide (HPEM) with site-unspecific radioiodination via [123I]I-para-iodobenzoate (PIB). [123I]I-HPEM was conjugated to the C-terminus of DARPin E01 via Glu-Glu-Glu-Cys ([123I]I-E01-E3C-HPEM) or Gly-Gly-Gly-Cys ([123I]I-E01-G3C-HPEM) linkers. Radiolabelling yields were 6 ± 2% and 13 ± 5%, respectively. Size-exclusion purification provided radiochemical purity > 98%. Both HPEM conjugates retained nanomolar EGFR-binding affinity (KD: 3.2 ± 0.6 and 4.8 ± 0.9 nM) and demonstrated EGFR-specific tumour accumulation in A-431 xenografts. Cellular processing was characterised by rapid binding, slow internalisation, and non-residualising behaviour of all variants. Kidney uptake was lower for the site-specifically labelled variants. However, site-specific labelling evidently elevated hepatobiliary excretion and uptake in Na/I-symporter-expressing organs compared to [123I]I-(HE)3-E01-PIB, while linker composition (E3C vs. G3C) did not significantly alter biodistribution. Site-unspecific radioiodination with [123I]I-PIB remains the preferred approach for clinical SPECT imaging of EGFR expression with DARPin E01.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Iodine RadioisotopesErbB ReceptorsMaleimidesRadiopharmaceuticalsAnimalsHumansTissue DistributionTomography, Emission-Computed, Single-PhotonMiceAnkyrin RepeatCell Line, TumorFemale

Stichwörter der Autor:innen

DARPin E01EGFRHPEMSPECTbiodistributionradioiodinationscaffold proteinsite-specific labelling

Substanzen

Iodine RadioisotopesErbB ReceptorsMaleimidesRadiopharmaceuticalsEGFR protein, human

Autor:innen und Institutionen

  • Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia.
  • Department of Pharmaceutical Analysis, Siberian State Medical University, 634050 Tomsk, Russia.
  • Polytechnic Institute of Nuclear Technology, National Research and Innovation Agency of Indonesia, Yogyakarta 55281, Indonesia.
  • Department of Nuclear Medicine, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634009 Tomsk, Russia.
  • Molecular Immunology Laboratory, Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
  • Collective Use Center "Bioorganic", Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.

ORCID-Profile: Mariia Larkina, Gleb Yanovich, Lutfi A Hasnowo, Ruslan Varvashenya, Anastasia Prach, Evgenii Plotnikov, Alexey Schulga, Elena Konovalova, Rustam H Ziganshin, Mikhail Belousov, Vladimir Tolmachev, Sergey M Deyev

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Larkina, M., Yanovich, G., Hasnowo, L. A., Varvashenya, R., Eskova, D., Sharychev, I., Prach, A., Plotnikov, E., Zelchan, R., Schulga, A., Konovalova, E., Ziganshin, R. H., Belousov, M., Tolmachev, V., & Deyev, S. M. (2026). Evaluation of Site-Specific Radioiodination of Anti-EGFR-Targeted DARPin E01 Using (4-Hydroxyphenyl)ethyl Maleimide. International Journal of Molecular Sciences, 27(16), 7438. https://doi.org/10.3390/ijms27167438

Vancouver

Larkina M, Yanovich G, Hasnowo LA, Varvashenya R, Eskova D, Sharychev I, et al. Evaluation of Site-Specific Radioiodination of Anti-EGFR-Targeted DARPin E01 Using (4-Hydroxyphenyl)ethyl Maleimide. International Journal of Molecular Sciences. 2026;27(16):7438. doi:10.3390/ijms27167438

BibTeX
@article{Larkina2026,
  author = {Larkina, Mariia and Yanovich, Gleb and Hasnowo, Lutfi A and Varvashenya, Ruslan and Eskova, Daria and Sharychev, Ivan and Prach, Anastasia and Plotnikov, Evgenii and Zelchan, Roman and Schulga, Alexey and Konovalova, Elena and Ziganshin, Rustam H and Belousov, Mikhail and Tolmachev, Vladimir and Deyev, Sergey M},
  title = {Evaluation of Site-Specific Radioiodination of Anti-EGFR-Targeted DARPin E01 Using (4-Hydroxyphenyl)ethyl Maleimide},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {16},
  pages = {7438},
  doi = {10.3390/ijms27167438}
}
Kostenlos starten →